ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Serum Fibroblast Growth Factor 19 as a Biomarker in Hepatitis B Virus-Related Liver Disease

Miao, Xin; Wu, Guicheng*; An, Xuan; Guo, Xiqing; Peng, Chuyan重庆大学
Hepatitis Monthly2022-12DOI: 10.5812/hepatmon-130652
7阅读
引用收藏
分享

摘要

Background: Past research has found that fibroblast growth factor 19 (FGF19) is associated with several hepatic disorders, such as alcoholic liver disease and primary biliary cirrhosis. However, there is currently a lack of relevant studies on the relationship between FGF19 and hepatitis B virus (HBV)-related liver disease. @@@ Objectives: This study aimed to assess the role of serum FGF19 as anewbiomarker for HBV-related liver disease and provide scientific data to show the clinical value of this biomarker. @@@ Methods: A retrospective study included 37 patients with chronic hepatitis B (CHB), 33 patients with HBV-related cirrhosis (HBVcirrhosis), and 32 patients with HBV-related hepatocellular carcinoma (HBV-HCC). Furthermore, 33 normal people were randomly selected as healthy controls. The serum levels of FGF19 were measured by ELISA. @@@ Results: Serum FGF19 levels were increased sequentially in the CHB group, HBV-cirrhosis group, and HBV-HCC group. Furthermore, serum FGF19 levels positively correlated with alpha-fetoprotein, prothrombin time, international normalized ratio, total bilirubin, direct bilirubin, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl-transferase, alkaline phosphatase, total bile acid, serum markers for liver fibrosis, ascites, cirrhosis, Child-Pugh classification and model for end-stage liver disease sodium (MELD-Na) score, while negatively correlated with platelet count, prothrombin activity, and albumin. The diagnostic threshold of serum FGF19 for HBV-related HCC was 165.32 pg/mL, with a sensitivity of 81.25% and specificity of 58.57%. @@@ Conclusions: Serum FGF19 levels are positively associated with cholestasis, hepatocyte damage, and liver fibrosis but negatively correlated with liver synthetic function and liver functional reserve in HBV-related liver disease. Diverse changes in serum FGF19 may be used as a predictive marker for the progression of HBV-related liver disease. In addition, serum FGF19 has a potential role in monitoring carcinogenesis in patients with HBV-related liver disease.

学科与关键词

关键词
Hepatitis B VirusChronic Hepatitis BCirrhosisHepatocellular CarcinomaFibroblast Growth Factor 19
相关
加载中…
  • Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B
    Argirion, Ilona*; Pfeiffer, Ruth M.; Lam, Tram Kim; O'Brien, Thomas R.; Yu, Kelly; McGlynn, Katherine A.; Petrick, Jessica L.; Pinto, Ligia; Chen, Chien-Jen; Lee, Mei-Hsuan; Hildesheim, Allan; Yang, Hwai-, I; Koshiol, Jill2021, 11(1): 21194.
  • Relationship between hepatitis B surface antigen, HBV DNA quantity and liver fibrosis severity
    郜玉峰; 邹桂舟; 叶珺; 潘高峰; 饶建国; 李芳; 魏艳艳; 李旭2015.
  • CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
    Yu, Xin; Chen, Ying; Cui, Lele; Yang, Kaming; Wang, Xumeng; Lei, Linyuan; Zhang, Yanping; Kong, Xinyi; Lao, Wanwen; Li, Zhenlin; Liu, Yang; Li, Yuetong; Bi, Changlong*; Wu, Chao*; Zhai, Aixia*Frontiers in Microbiology, 2022, 13: 1052917.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Hepatitis Monthly
发表日期
2022-12
卷期
第 22 卷, 第 1 期
页码
e130652
DOI
10.5812/hepatmon-130652
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81873571]; Chongqing Natural Science Foundation [cstc2019jcyj-msxmX0774]

作者

  • M

    Miao, Xin (第一作者)

  • W

    Wu, Guicheng (通讯)

    chongqing univ

查看全部 5 位作者收起作者
  • A

    An, Xuan

    chongqing univ

  • G

    Guo, Xiqing

    chongqing univ

  • P

    Peng, Chuyan

    chongqing univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417